Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
enVVeno MedicalNVNO -0.91%26 EV-to-FCF is 1.15 as of Jul. 14, 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 414 Medical Devices & Instruments companies, enVVeno Medical ranks better than 97.34% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, enVVeno Medical's Enterprise Value is $-17.05 Mil.
enVVeno Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-14.79 Mil. Therefore, enVVeno Medical's EV-to-FCF for today is 1.15.
The historical rank and industry rank for enVVeno Medical's EV-to-FCF or its related term are showing as below:
NVNO'
s EV-to-FCF Range Over the Past 10 Years
Min: -10.86 Med: -0.61 Max: 1.15
Current: 1.15
During the past 11 years, the highest EV-to-FCF of enVVeno Medical was 1.15. The lowest was -10.86. And the median was -0.61.
NVNO's EV-to-FCF is ranked better than 97.34% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs NVNO: 1.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
enVVeno Medical's PE Ratio (TTM) for today is calculated as:
enVVeno Medical's share price for today is $10.90.
enVVeno Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-31.250.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
enVVeno Medical EV-to-FCF Related Terms
enVVeno Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for enVVeno Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, enVVeno Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
enVVeno Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, enVVeno Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where enVVeno Medical's EV-to-FCF falls into.
enVVeno Medical's current Enterprise Value is $-17.05 Mil.
enVVeno Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.79 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
enVVeno Medical (NVNO) has a EV-to-FCF of 1.15 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on enVVeno Medical and its competitors. According to the industry distribution chart, enVVeno Medical ranks #11 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 2.7%.
Is enVVeno Medical's EV-to-FCF too high?
enVVeno Medical's current EV-to-FCF is 1.15. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. enVVeno Medical's value of 1.15 is 95.1% below this industry median. Based on the distribution chart, enVVeno Medical ranks #11 out of 414 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's EV-to-FCF compare to STME and TRIB?
According to the Medical Devices & Instruments industry distribution chart, enVVeno Medical ranks #11 out of 414 companies for EV-to-FCF. This places enVVeno Medical in the top 3% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.45. enVVeno Medical's value of 1.15 is 95.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. enVVeno Medical's current EV-to-FCF of 1.15 is 95.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on enVVeno Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. enVVeno Medical's current EV-to-FCF is 1.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current EV-to-FCF of 1.15. The current EV-to-FCF is 1.15 and 95.1% below the Medical Devices & Instruments industry median of 23.45. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current EV-to-FCF is 1.15 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score
Get the complete analysis for NVNO
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVNO has been successfully added to your 
